Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624804 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
A Phase 1 study, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT02624804 is a Phase 1 study that has completed, run by Hackensack Meridian Health. The registered enrollment target is 13 participants.
The verdict
NCT02624804, a Phase 1 study, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a prospective, single arm, open-label, single-center pilot study to assess the safety, feasibility, and efficacy of Stem Cell Educator therapy for the treatment of patients with Type 1 Diabetes.
Interventions
- BIOLOGICAL Stem Cell Educator Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2024-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02624804
The ClinicalTrials.gov registry entry for NCT02624804 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stem Cell Educator Therapy is the first listed.
NCT02624804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02624804 about?
NCT02624804 is a clinical study titled "A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes". This is a prospective, single arm, open-label, single-center pilot study to assess the safety, feasibility, and efficacy of Stem Cell Educator therapy for the treatment of patients with Type 1 Diabetes.
What is the current status of trial NCT02624804?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2017-06-27. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT02624804?
The interventions under investigation include: Stem Cell Educator Therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT02624804?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.